EUVIMEDEUVIMED entdecken
Crossref

Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics

Ruyang Cheng iD, Weining Song, Yu Wang, Yehao Wang, Xiaomin Xu, Fang Lu, Donghua Yu iD, Pingping Chen, Shumin Liu iD

Biomedical Chromatography · 2026-08 · 40 (8)

DOI: 10.1002/bmc.70534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 03.07.2026. Verfasst von Ruyang Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China. Hauptthemen laut MEDLINE: Pancreatitis, Chronic, Flavonoids, Metabolome. Die Arbeit nennt 69 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we explored the therapeutic effects and mechanisms of baicalin (BA) in a dibutyltin dichloride (DBTC)–induced chronic pancreatitis (CP) rat model using metabolomics and network pharmacology. The results showed that BA significantly reduced inflammatory cell infiltration and fibrosis in pancreatic tissues, lowered serum levels of interleukin (IL)‐1β, IL‐6, tumor necrosis factor‐alpha (TNF‐α), amylase (AMS), and lipopolysaccharide (LPS) and thereby decreased expression of alpha‐smooth muscle actin (α‐SMA) and fibronectin (FN) in pancreatic tissues. Metabolomic analyses revealed that BA influences multiple metabolic pathways, including glycerophospholipid and arachidonic acid metabolism, in serum and urine. Network pharmacology identified key targets, such as phospholipase A2 group IVA (PLA2G4A) and transient receptor potential vanilloid 4 (TRPV4), which are primarily involved in IL‐17 signaling, as well as other pathways beyond inflammation. Further integrated analysis demonstrated that BA inhibits pancreatic stellate cell activation and reduces pancreatic fibrosis by regulating metabolites, such as arachidonic acid, that act on the PLA2G4A/TRPV4 and transforming growth factor‐beta 1 (TGF‐β1)/SMAD family member 3 (SMAD3) pathways. Molecular docking studies confirmed that BA binds strongly to these targets. In summary, BA exerts anti‐inflammatory and antifibrotic effects through multiple targets and pathways, thereby alleviating the pathological progression of CP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatitis, ChronicFlavonoidsMetabolomeAnimalsMetabolomicsRatsMaleNetwork PharmacologyMolecular Docking SimulationRats, Sprague-DawleyOrganotin CompoundsPancreas

Stichwörter der Autor:innen

baicalinchronic pancreatitisinflammationmetabolomicsnetwork pharmacology

Substanzen

baicalinFlavonoidsOrganotin Compoundsdibutyldichlorotin

Autor:innen und Institutionen

  • Institute of Traditional Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin, China.

ORCID-Profile: Ruyang Cheng, Donghua Yu, Shumin Liu

Zitieren

APA

Cheng, R., Song, W., Wang, Y., Wang, Y., Xu, X., Lu, F., Yu, D., Chen, P., & Liu, S. (2026). Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics. Biomedical Chromatography, 40(8). https://doi.org/10.1002/bmc.70534

Vancouver

Cheng R, Song W, Wang Y, Wang Y, Xu X, Lu F, et al. Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics. Biomedical Chromatography. 2026;40(8). doi:10.1002/bmc.70534

BibTeX
@article{Cheng2026,
  author = {Cheng, Ruyang and Song, Weining and Wang, Yu and Wang, Yehao and Xu, Xiaomin and Lu, Fang and Yu, Donghua and Chen, Pingping and Liu, Shumin},
  title = {Molecular Mechanism of Baicalin in Ameliorating Chronic Pancreatitis: Insights From Network Pharmacology and Metabolomics},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1002/bmc.70534}
}
Kostenlos starten →